Integration of proteomics and transcriptomics to construct a prognostic signature of renal clear cell carcinoma

被引:1
|
作者
Cheng, Guangyang [1 ]
Zhou, Zhaokai [1 ,2 ,3 ]
Li, Shiqi [1 ]
Ye, Zhuo [1 ]
Wang, Yan [1 ]
Wen, Jianguo [1 ,2 ,3 ]
Ren, Chuanchuan [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Henan Joint Int Pediat Urodynam Lab, Zhengzhou 450052, Henan, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Bladder Struct & Funct Reconstruct Henan Engn Lab, Zhengzhou 450052, Henan, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Proteomics; Transcriptomics; Renal clear cell carcinoma; Prognostic signature; tumor microenvironment; CANCER; P21; IDENTIFICATION; EFFICACY; RPS6KB1;
D O I
10.7150/ijms.99992
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Protein information is often replaced by RNA data in studies to understand cancer-related biological processes or molecular functions, and proteins of prognostic significance in Kidney clear cell carcinoma (KIRC) remain to be mined. Methods: The cancer genome atlas program (TCGA) data was utilized to screen for proteins that are prognostically significant in KIRC. Machine learning algorithms were employed to develop protein immunotherapeutic responses were analyzed in various protein risk subgroups. Ultimately, the validation of protein-coding genes was confirmed by utilizing an online database and implementing quantitative Results: The patients were divided into two risk categories based on prognostic proteins, and notable disparities in both overall survival (OS) and progression free interval (PFI) were observed between the two groups. The OS was more unfavorable in the high-risk group, and there was a noteworthy disparity in the level of immune infiltration observed between the two groups. In addition, the nomogram showed high accuracy in predicting survival in KIRC patients. Conclusion: In this research, we elucidated the core proteins associated with prognosis in terms of survival prediction, immunotherapeutic response, somatic mutation, and immune microenvironment. Additionally, we have developed a reliable prognostic model with excellent predictive capabilities.
引用
收藏
页码:2215 / 2232
页数:18
相关论文
共 50 条
  • [21] A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma
    Pei, Dongchen
    Xu, Chaojie
    Wang, Dong
    Shi, Xiaoxue
    Zhang, Yurui
    Liu, Yi
    Guo, Jianhua
    Liu, Nan
    Zhu, Haipeng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
    Jin Zhang
    Aiting Yan
    Wei Cao
    Honglei Shi
    Kai Cao
    Xiaowu Liu
    Cancer Cell International, 20
  • [23] An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma
    Wu, Yue
    Wei, Xian
    Feng, Huan
    Hu, Bintao
    Liu, Bo
    Luan, Yang
    Ruan, Yajun
    Liu, Xiaming
    Liu, Zhuo
    Wang, Shaogang
    Liu, Jihong
    Wang, Tao
    AGING-US, 2020, 12 (22): : 23165 - 23186
  • [24] Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
    Li, Zhengtian
    Du, Gang
    Zhao, Rong
    Yang, Wenkang
    Li, Chan
    Huang, Jun
    Wen, Zhenpei
    Li, Hening
    Zhang, Bo
    MEDICINE, 2021, 100 (39)
  • [25] Development of a SETD2-related immune prognostic signature in clear cell renal cell carcinoma
    Wang, Xingyuan
    Xia, Zhinan
    Li, Zhiyuan
    Zhang, Cheng
    MEDICINE, 2022, 101 (31)
  • [26] Validation of a 15-gene prognostic signature in metastatic clear cell renal cell carcinoma.
    Monda, Steven
    Nallandhighal, Srinivas
    Vaishampayan, Ulka N.
    Singhal, Udit
    Knuth, Zayne
    Mehra, Rohit
    Kaffenberger, Samuel
    Hafez, Khaled
    Udager, Aaron M.
    Palapattu, Ganesh S.
    Morgan, Todd Matthew
    Salami, Simpa Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [27] Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma
    Shen, Chengquan
    Liu, Jing
    Wang, Jirong
    Zhong, Xiulong
    Dong, Dahai
    Yang, Xiaokun
    Wang, Yonghua
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 81
  • [28] Integrated Analysis to Identify a Redox-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
    Wu, Yue
    Wei, Xian
    Feng, Huan
    Hu, Bintao
    Liu, Bo
    Luan, Yang
    Ruan, Yajun
    Liu, Xiaming
    Liu, Zhuo
    Liu, Jihong
    Wang, Tao
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [29] Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
    Liu, Yankuo
    Shi, Zhiyuan
    Zheng, Jianzhong
    Zheng, Zeyuan
    Sun, Huimin
    Xuan, Zuodong
    Bai, Yang
    Fu, Meiling
    Du, Yifan
    Shao, Chen
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] WHOLE TRANSCRIPTOME SEQUENCING OF CLEAR CELL RENAL CELL CARCINOMA REVEALS A MULTIGENE EXPRESSION PROGNOSTIC SIGNATURE
    Nallandhighal, Srinivas
    Mehra, Rohit
    Cieslik, Marcin
    Kasputis, Amy
    Cotta, Brittney
    Morgan, Todd
    Salami, Simpa
    JOURNAL OF UROLOGY, 2022, 207 (05): : E33 - E33